The importance of electroencephalography in the diagnosis of hepatic encephalopathy due to cirrhosis – a case report
DOI:
https://doi.org/10.15584/ejcem.2022.2.12Keywords:
ammonia, cirrhosis, electroencephalography, encephalopathy, triphasic wavesAbstract
Introduction and aim. Hepatic encephalopathy (HE) associated with cirrhosis of the liver is a neuropsychiatric syndrome, with symptoms ranging from barely detectable changes to deep coma. It frequently occurs in the form of episodes and relapses and can be triggered by external factors. HE severity is graded according to the West Haven criteria. The aim of the study is to draw attention to the ever-important and often key role of electroencephalography in the diagnosis of hepatic encephalopathy, even in today’s era of increasingly advanced diagnostic methods.
Description of the case. A 57-year-old patient, professionally active at the time, was admitted to the hospital’s Neurology Department on an emergency basis due to difficulties with standing and moving, orientation disorders and limb tremor.
Conclusion. While HE pathogenesis is multifactorial, the most important factors include increased brain exposure to ammonia, intestinal dysbiosis, and endotoxemia inducing a systemic inflammatory response. Patient observation, blood laboratory tests, neuropsychological tests and neurophysiological tests (EEG and evoked potentials) play an important role in establishing the diagnosis. Treatment and secondary prevention of hepatic encephalopathy include elimination of triggers and reduction of ammonia production and improvement of its metabolism.
Downloads
References
Elwir S, Rahimi RS. Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options. J Clin Transl Hepatol. 2017;5(2):142-151. doi:10.14218/JCTH.2016.00069
Ridola L, Riggio O, Gioia S, Faccioli J, Nardelli S. Clinical management of type C hepatic encephalopathy. United European Gastroenterology Journal. 2020;8(5):536-543. doi:10.1177/2050640620909675
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245-266. doi:10.1016/S2468-1253(19)30349-8
Shawcross DL, Olde Damink SWM, Butterworth RF, Jalan R. Ammonia and hepatic encephalopathy: the more things change, the more they remain the same. Metab Brain Dis. 2005;20(3):169-179. doi:10.1007/s11011-005-7205-0
Mohiuddin SS, Khattar D. Biochemistry, Ammonia. In: StatPearls. StatPearls Publishing; 2022. Accessed February 20, 2022. http://www.ncbi.nlm.nih.gov/books/NBK541039/
Yoshida Y, Higashi T, Nouso K, et al. Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis. Acta Med Okayama. 2001;55(6):349-355. doi:10.18926/AMO/32003
Fiati Kenston SS, Song X, Li Z, Zhao J. Mechanistic insight, diagnosis, and treatment of ammonia-induced hepatic encephalopathy. Journal of Gastroenterology and Hepatology. 2019;34(1):31-39. doi:10.1111/jgh.14408
Aldridge DR, Tranah EJ, Shawcross DL. Pathogenesis of Hepatic Encephalopathy: Role of Ammonia and Systemic Inflammation. J Clin Exp Hepatol. 2015;5(Suppl 1):S7-S20. doi:10.1016/j.jceh.2014.06.004
Jayakumar AR, Norenberg MD. Hyperammonemia in Hepatic Encephalopathy. J Clin Exp Hepatol. 2018;8(3):272-280. doi:10.1016/j.jceh.2018.06.007
Ferenci P. Hepatic encephalopathy. Gastroenterol Rep (Oxf). 2017;5(2):138-147. doi:10.1093/gastro/gox013
Bruyneel M, Sersté T. Sleep disturbances in patients with liver cirrhosis: prevalence, impact, and management challenges. Nat Sci Sleep. 2018;10:369-375. doi:10.2147/NSS.S186665
Cordoba J. Hepatic Encephalopathy: From the Pathogenesis to the New Treatments. ISRN Hepatol. 2014;2014:236268. doi:10.1155/2014/236268
Weissenborn K. Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles. Drugs. 2019;79(Suppl 1):5-9. doi:10.1007/s40265-018-1018-z
Stinton LM, Jayakumar S. Minimal hepatic encephalopathy. Can J Gastroenterol. 2013;27(10):572-574.
Zhan T, Stremmel W. The Diagnosis and Treatment of Minimal Hepatic Encephalopathy. Dtsch Arztebl Int. 2012;109(10):180-187. doi:10.3238/arztebl.2012.0180
Mandiga P, Foris LA, Bollu PC. Hepatic Encephalopathy. In: StatPearls. StatPearls Publishing; 2022. Accessed February 20, 2022. http://www.ncbi.nlm.nih.gov/books/NBK430869/
Kori P, Sahu R, Jaiswal A, Shukla R. Hepatic myelopathy: an unusual neurological complication of chronic liver disease presenting as quadriparesis. BMJ Case Rep. 2013;2013:bcr2013009078. doi:10.1136/bcr-2013-009078
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. Journal of Hepatology. 2014;61(3):642-659. doi:10.1016/j.jhep.2014.05.042
Step by Step: Managing the Complications of Cirrhosis | HMER. Accessed February 20, 2022. https://www.dovepress.com/step-by-step-managing-the-complications-of-cirrhosis-peer-reviewed-fulltext-article-HMER
Amodio P, Montagnese S. Clinical Neurophysiology of Hepatic Encephalopathy. J Clin Exp Hepatol. 2015;5(Suppl 1):60-68. doi:10.1016/j.jceh.2014.06.007
Koul R, Maiwall R, Ramalingam A, et al. Role of EEG in Predicting Outcome of Hepatic Encephalopathy Patients. Neurodiagn J. 2020;60(4):272-288. doi:10.1080/21646821.2020.1824959
Chavarria L, Cordoba J. Magnetic Resonance Imaging and Spectroscopy in Hepatic Encephalopathy. J Clin Exp Hepatol. 2015;5(Suppl 1):S69-S74. doi:10.1016/j.jceh.2013.10.001
Bleibel W, Al-Osaimi AMS. Hepatic Encephalopathy. Saudi J Gastroenterol. 2012;18(5):301-309. doi:10.4103/1319-3767.101123
Karanfilian BV, Cheung M, Dellatore P, Park T, Rustgi VK. Laboratory Abnormalities of Hepatic Encephalopathy. Clin Liver Dis. 2020;24(2):197-208. doi:10.1016/j.cld.2020.01.011
Swaminathan M, Ellul MA, Cross TJ. Hepatic encephalopathy: current challenges and future prospects. Hepat Med. 2018;10:1-11. doi:10.2147/HMER.S118964
Marchetti P, D’Avanzo C, Orsato R, et al. Electroencephalography in Patients With Cirrhosis. Gastroenterology. 2011;141(5):1680-1689.e2. doi:10.1053/j.gastro.2011.06.085
Togo M, Kinoshita M. Hepatic encephalopathy revisited: Beyond the triphasic waves. Clin Neurophysiol. 2019;130(3):408-409. doi:10.1016/j.clinph.2018.12.003
Hawkes ND, Thomas G a. O, Jurewicz A, et al. Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy. Postgraduate Medical Journal. 2001;77(913):717-722. doi:10.1136/pmj.77.913.717
Rayi A, Mandalaneni K. Encephalopathic EEG Patterns. In: StatPearls. StatPearls Publishing; 2022. Accessed February 20, 2022. http://www.ncbi.nlm.nih.gov/books/NBK564371/
Emmady PD, Murr N. EEG Triphasic Waves. In: StatPearls. StatPearls Publishing; 2022. Accessed February 20, 2022. http://www.ncbi.nlm.nih.gov/books/NBK557679/
Davies MG, Rowan MJ, Feely J. EEG and event related potentials in hepatic encephalopathy. Metab Brain Dis. 1991;6(4):175-186. doi:10.1007/BF00996917
van der Rijt CC, Schalm SW. Quantitative EEG analysis and evoked potentials to measure (latent) hepatic encephalopathy. J Hepatol. 1992;14(2-3):141-142. doi:10.1016/0168-8278(92)90148-i
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
